VanEck Associates’s Insulet PODD Stock Holding History
Bought
Maintained
Sold
Other funds holding PODD
VanEck Associates's PODD Position: Q2 2026 in Review
VanEck Associates increased its Insulet (PODD) stake by 11% in Q2 2026, buying an estimated $310K and bringing the position to 18,919 shares worth $2.88M. The position accounts for ﹤0.01% of the portfolio, ranked #959.
VanEck Associates first reported a position in PODD in Q2 2021 and has held it in 21 quarters since. The position peaked at $3.58M in Q1 2026. 720 funds tracked by Wall St. Rank hold PODD as of Q2 2026.
- VanEck Associates held 18,919 shares of Insulet worth $2.88M as of Q2 2026.
- VanEck Associates bought 1,858 Insulet shares in Q2 2026, an estimated $310K.
- Insulet made up ﹤0.01% of VanEck Associates's portfolio in Q2 2026, its #959 holding.
- VanEck Associates first reported a position in Insulet in Q2 2021 and has held it in 21 quarters since.
- VanEck Associates's Insulet position peaked at $3.58M in Q1 2026.
- 720 funds tracked by Wall St. Rank held Insulet as of Q2 2026.
Based on VanEck Associates's 13F filing for Q2 2026, filed 14 Aug 2026.